Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
· tonix pharmaceuticals holding corp.
AI Briefing
- Tonix Pharmaceuticals reports successful launch of TONMYA for fibromyalgia treatment.
- Over 1,500 healthcare providers have prescribed TONMYA through February 2026.
- Approximately 2,500 patients have initiated treatment and 4,200 cumulative prescriptions.
Advertisement